BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE]

Side Effects & Adverse Event Reports


View Chart Data

29K

Adverse Events

414.6K

Side Effects

2003

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE].

Understanding the potential Side Effects and Adverse Events of BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE]?

    SymPedia shows BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] adverse event reports for 28,967.

  • How many side effects have been reported for BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE]?

    SymPedia shows BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] side effect reports for 414,556.

  • What year does the BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE] reporting data start?

    SymPedia reporting data on this page starts in 2003.

  • What years are included in the yearly chart for BROMPHENIRAMINE MALEATE 0.266 MG/ML / CODEINE PHOSPHATE 1.27 MG/ML / PHENYLEPHRINE HYDROCHLORIDE 0.666 MG/ML ORAL SOLUTION [M-END PE]?

    SymPedia yearly chart data on this page covers 2003 to 2025.